How have XPH shares performed in 2024?

SPDR S&P Pharmaceuticals ETF's stock was trading at $41.62 on January 1st, 2024. Since then, XPH shares have decreased by 6.1% and is now trading at $39.10. View the best growth stocks for 2024 here .

What does XPH invest in?

SPDR S&P Pharmaceuticals ETF is a equity fund issued by SSgA. XPH focuses on health care investments and follows the S&P Pharmaceuticals Index. The fund's investments total to approximately $192.05 million assets under management.

What stocks does SPDR S&P Pharmaceuticals ETF hold?

XPH invests in 42 holdings. Some of the stocks in their portfolio include Merck & Co., Inc. (MRK) , Perrigo (PRGO) , Catalent (CTLT) , Intra-Cellular Therapies (ITCI) , Eli Lilly and Company (LLY) , Organon & Co. (OGN) , Axsome Therapeutics (AXSM) , Pfizer (PFE) , Jazz Pharmaceuticals (JAZZ) and Royalty Pharma (RPRX) .

What is the management fee for SPDR S&P Pharmaceuticals ETF?

SPDR S&P Pharmaceuticals ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for XPH is 0.35%.

What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Pharmaceuticals ETF investors own include Pfizer (PFE) , Bank of America (BAC) , Micron Technology (MU) , Broadcom (AVGO) , Chevron (CVX) , DocuSign (DOCU) , SPDR Gold Shares (GLD) , International Business Machines (IBM) , JPMorgan Chase & Co. (JPM) and AT&T (T) .

How do I buy shares of SPDR S&P Pharmaceuticals ETF?

Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEARCA:XPH

SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free XPH Stock Alerts

$39.10

-0.48 (-1.21%)

(As of 04/18/2024 ET)

Compare

Today's Range: $39.10
▼
$39.52
50-Day Range: $39.10
▼
$45.55
52-Week Range: $34.67
▼
$45.62

Volume: 11,682 shs
Average Volume: 43,766 shs
Market Capitalization: $191.59 million

Assets Under Management: $192.05 million
Dividend Yield: 1.71%
Net Expense Ratio: 0.35%

Stock Analysis Chart Headlines Holdings Ownership Ratings

Get SPDR S&P Pharmaceuticals ETF alerts:

About SPDR S&P Pharmaceuticals ETF

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

XPH Stock Price History

30 days | 90 days | 365 days | Advanced Chart

XPH ETF News Headlines

March 30, 2024 | finance.yahoo.com

SPDR S&P Pharmaceuticals ETF (XPH)

March 28, 2024 | seekingalpha.com

XPH: A More Balanced Way To Get Exposure To Pharmaceuticals

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 16, 2024 | wsj.com

SPDR S&P Pharmaceuticals ETF

February 5, 2024 | usatoday.com

S&P 500 (SPX) today: Catalent Inc is a top mover, up 10%

December 23, 2023 | benzinga.com

SPDR S&P Pharmaceuticals ETF (ARCA:XPH), Quotes and News Summary

December 18, 2023 | msn.com

SPDR S&P Pharmaceuticals ETF declares quarterly distribution of $0.1744

November 6, 2023 | marketwatch.com

Why the S&P 500 ETF’s rare triple ‘gap ups’ isn’t a buy signal

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

October 29, 2023 | investing.com

XPH ETF Stock Price History

See More Headlines

Receive XPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: SSgA
Fund Name: SPDR S&P Pharmaceuticals ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NYSEARCA
Current Symbol: NYSEARCA:XPH
Inception Date: 6/19/2006
Fund Manager: Michael Feehily, Karl Schneider, Keith Richardson
Web: www.spdrs.com
Phone: +1-617-6644738

Fund Focus

Asset Class: Equity
Benchmark: S&P Pharmaceuticals Index
Category: Sector
Focus: Health Care
Development Level: Developed Markets
Region: North America
Number of Holdings: 42

Fund Statistics

Assets Under Management: $192.05 million
Average Daily Volume: $43,395.90
Discount/Premium: -0.02%

Administrator, Advisor and Custodian

Administrator: SSgA Funds Management, Inc.
Advisor: SSgA Funds Management, Inc.
Custodian: State Street Bank and Trust Company
Distributor: State Street Global Advisors Funds Distributors, LLC
Transfer Agent: State Street Bank and Trust Company
Trustee: N/A
Lead Market Maker: Citadel

Options

Optionable: N/A
Short Interest: 345,900 shs

Miscellaneous

Outstanding Shares: 4,900,000
Beta: 0.87
Creation Unit: 50,000
Creation Fee: $250.00

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

SPDR S&P Pharmaceuticals ETF Expenses

Type	XPH	Health Care ETFs	Equity ETFs	NYSEARCA ETFs	All ETFs
Management Fee	0.35%	0.56%	0.54%	0.50%	0.51%
Other Expenses	0.00%	0.40%	0.54%	0.64%	0.58%
Total Expense	0.35%	0.72%	0.70%	0.74%	0.70%
Fee Waiver	0.00%	-0.53%	-0.55%	-0.68%	-0.57%
Net Expense	0.35%	0.60%	0.60%	0.58%	0.58%

SPDR S&P Pharmaceuticals ETF (XPH) Holdings & Exposure

Top 10 XPH Holdings

XPH Sector Exposure

XPH Industry Exposure

Full Holdings Details

Key Executives

James E. Ross (Age 52)
President, Trustee
Peter A. Ambrosini (Age 69)
Chief Compliance Officer
Michael P. Riley (Age 44)
Vice President
Gary L. French (Age 64)
Treasurer
John W. Clark (Age 46)
Assistant Treasurer
Matthew W. Flaherty (Age 42)
Assistant Treasurer
Chad C. Hallett (Age 47)
Assistant Treasurer of Street tracks series trust
Mary Moran Zeven (Age 52)
Secretary
Scott M. Zoltowski (Age 44)
Assistant Secretary
Dave Kelly
Independent Trustee

Similar ETFs

Institutional Ownership

View All Institutional Transactions

XPH ETF - Frequently Asked Questions

How have XPH shares performed in 2024?: SPDR S&P Pharmaceuticals ETF's stock was trading at $41.62 on January 1st, 2024. Since then, XPH shares have decreased by 6.1% and is now trading at $39.10.
View the best growth stocks for 2024 here.
What does XPH invest in?: SPDR S&P Pharmaceuticals ETF is a equity fund issued by SSgA. XPH focuses on health care investments and follows the S&P Pharmaceuticals Index. The fund's investments total to approximately $192.05 million assets under management.
What stocks does SPDR S&P Pharmaceuticals ETF hold?: XPH invests in 42 holdings. Some of the stocks in their portfolio include Merck & Co., Inc. (MRK), Perrigo (PRGO), Catalent (CTLT), Intra-Cellular Therapies (ITCI), Eli Lilly and Company (LLY), Organon & Co. (OGN), Axsome Therapeutics (AXSM), Pfizer (PFE), Jazz Pharmaceuticals (JAZZ) and Royalty Pharma (RPRX).
What is the management fee for SPDR S&P Pharmaceuticals ETF?: SPDR S&P Pharmaceuticals ETF's management fee is 0.35% and has no other recorded expenses or fee waivers. The net expense ratio for XPH is 0.35%.

What other stocks do shareholders of SPDR S&P Pharmaceuticals ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Pharmaceuticals ETF investors own include Pfizer (PFE), Bank of America (BAC), Micron Technology (MU), Broadcom (AVGO), Chevron (CVX), DocuSign (DOCU), SPDR Gold Shares (GLD), International Business Machines (IBM), JPMorgan Chase & Co. (JPM) and AT&T (T).
How do I buy shares of SPDR S&P Pharmaceuticals ETF?: Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:XPH) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News

About SPDR S&P Pharmaceuticals ETF

XPH Stock Price History

XPH ETF News Headlines

Fund Details

Fund Focus

Fund Statistics

Administrator, Advisor and Custodian

Options

Miscellaneous

SPDR S&P Pharmaceuticals ETF Expenses

SPDR S&P Pharmaceuticals ETF (XPH) Holdings & Exposure

Top 10 XPH Holdings

XPH Sector Exposure

XPH Industry Exposure

Key Executives

Similar ETFs

Institutional Ownership

XPH ETF - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info